Volume 23, supplement 3, Décembre 2016

Éditorial

Toward personalized medicine in inflammatory bowel diseases: from CESAME to I-CARE (p.4-9)
Laurent Beaugerie, Vered Abitbol, Stéphane Nahon, Laurent Peyrin-Biroulet
Free Access

Mini-Revues

The real-life experience with vedolizumab (p.10-6)
Aurélien Amiot, Yoram Bouhnik
Free Access

Therapeutic drug monitoring in inflammatory bowel diseases: indications in clinical practice (p.17-26)
Xavier Roblin, Stéphane Nancey
Free Access

Primary sclerosing cholangitis and inflammatory bowel disease (p.27-34)
David Laharie, Victor de Lédinghen
Free Access

Should we obtain histological healing in patients with ulcerative colitis? (p.35-41)
Jérôme Filippi, Xavier Hébuterne
Free Access